eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
eHealth (Nasdaq: EHTH) announced inducement grants for incoming CEO Derrick Duke, who will succeed Fran Soistman effective September 18, 2025. Duke joined the company on August 4, 2025 to begin the transition process.
The Compensation Committee granted Duke two restricted stock unit (RSU) awards under the company's Amended and Restated 2021 Inducement Plan. The first award of 300,000 shares vests over three years, while the second award of 300,000 shares is performance-based, vesting upon achievement of company goals between fiscal 2025 and 2027.
eHealth (Nasdaq: EHTH) ha comunicato le assegnazioni di incentivi per il futuro CEO Derrick Duke, che succeder脿 a Fran Soistman a partire dal 18 settembre 2025. Duke 猫 entrato in azienda il 4 agosto 2025 per avviare il periodo di transizione.
Il Comitato per la remunerazione ha concesso a Duke due premi in unit脿 di azioni vincolate (RSU) nell'ambito dell'Amended and Restated 2021 Inducement Plan della societ脿. Il primo premio di 300.000 azioni matura in tre anni; il secondo premio di 300.000 azioni 猫 legato a risultati e matura al conseguimento degli obiettivi aziendali per gli esercizi fiscali 2025-2027.
eHealth (Nasdaq: EHTH) anunci贸 adjudicaciones por inducement para el pr贸ximo director ejecutivo Derrick Duke, quien reemplazar谩 a Fran Soistman a partir del 18 de septiembre de 2025. Duke se incorpor贸 a la compa帽铆a el 4 de agosto de 2025 para iniciar la transici贸n.
El Comit茅 de Compensaci贸n otorg贸 a Duke dos premios en unidades restringidas de acciones (RSU) bajo el Amended and Restated 2021 Inducement Plan de la empresa. El primer premio de 300,000 acciones se devenga en tres a帽os; el segundo premio de 300,000 acciones es por desempe帽o y se devenga al alcanzar las metas de la compa帽铆a entre los ejercicios fiscales 2025 y 2027.
eHealth (Nasdaq: EHTH)電� 鞁犾瀯 CEO Derrick Duke鞐愱矊 攵�鞐悳 鞚胳劶韹半笇毳� 氚滍憸頄堨姷雼堧嫟. Duke電� 2025雲� 9鞗� 18鞚�攵�搿� Fran Soistman鞚� 霋るゼ 鞚挫柎 CEO搿� 旆瀯頃╇媹雼�. 鞝勴櫂 鞝堨皑毳� 鞙勴暣 Duke電� 2025雲� 8鞗� 4鞚�鞐� 須岇偓鞐� 頃╇頄堨姷雼堧嫟.
氤挫儊鞙勳洂須岆姅 須岇偓鞚� Amended and Restated 2021 Inducement Plan鞐� 霐半澕 Duke鞐愱矊 霊� 瓯挫潣 鞝滍暅欤检嫕雼渼(RSU)毳� 攵�鞐枅鞀惦媹雼�. 觳� 氩堨Ц電� 300,000欤�搿� 3雲� 霃欖晥 靾滌皑鞝侅溂搿� 靹膘垯頃橂┌, 霊� 氩堨Ц 300,000欤�電� 靹标臣 旮半皹鞙茧 2025~2027 須岅硠鞐半弰 霃欖晥 須岇偓 氇╉憸 雼劚 鞁� 靹膘垯頃╇媹雼�.
eHealth (Nasdaq: EHTH) a annonc茅 des attributions d'incitatifs pour son futur PDG Derrick Duke, qui succ茅dera 脿 Fran Soistman 脿 compter du 18 septembre 2025. Duke a rejoint la soci茅t茅 le 4 ao没t 2025 pour entamer la transition.
Le comit茅 de r茅mun茅ration a attribu茅 脿 Duke deux attributions en unit茅s d'actions restreintes (RSU) dans le cadre de l'Amended and Restated 2021 Inducement Plan de la soci茅t茅. La premi猫re attribution de 300 000 actions se lib猫re sur trois ans ; la seconde, de 300 000 actions, est conditionn茅e 脿 la performance et se lib猫re 脿 l'atteinte des objectifs de l'entreprise sur les exercices 2025 脿 2027.
eHealth (Nasdaq: EHTH) k眉ndigte Anreizzuweisungen f眉r den k眉nftigen CEO Derrick Duke an, der Fran Soistman mit Wirkung zum 18. September 2025 abl枚sen wird. Duke trat am 4. August 2025 in das Unternehmen ein, um den 脺bergang einzuleiten.
Das Verg眉tungskomitee gew盲hrte Duke zwei Restricted Stock Unit (RSU)-Awards im Rahmen des ge盲nderten und neu gefassten 2021 Inducement-Plans des Unternehmens. Die erste Zuteilung 眉ber 300.000 Aktien vestet 眉ber drei Jahre; die zweite Zuteilung 眉ber 300.000 Aktien ist leistungsabh盲ngig und vestet bei Erreichen der Unternehmensziele f眉r die Gesch盲ftsjahre 2025 bis 2027.
- Structured transition period planned between current and new CEO
- Performance-based RSUs align new CEO compensation with company goals
- Significant potential shareholder dilution with 600,000 total RSUs granted
Insights
eHealth's CEO transition includes substantial equity incentives aligning Derrick Duke's compensation with company performance and shareholder interests.
eHealth has announced a significant leadership transition with Derrick Duke set to replace Fran Soistman as CEO effective September 18, 2025. The compensation structure for Duke reveals a substantial equity-based incentive package designed to align his interests with company performance and shareholder value.
The structure of Duke's compensation is particularly telling. He received two distinct restricted stock unit (RSU) awards totaling 600,000 shares. The first 300,000-share grant follows a traditional time-based vesting schedule over three years, serving as a retention mechanism. More strategically significant is the second 300,000-share grant, which is entirely performance-contingent, based on company goals through fiscal 2027.
This 50/50 split between time-based and performance-based equity represents a balanced approach to executive compensation. It provides guaranteed compensation to attract and retain the executive while ensuring half of the equity value is directly tied to company performance metrics. This structure sends a positive signal about the board's commitment to pay-for-performance principles.
The size of the award (600,000 shares total) indicates the board's willingness to provide substantial equity to secure their preferred candidate. The three-year performance period suggests the board is focused on sustainable medium-term growth rather than short-term metrics, which aligns with sound governance practices.
Importantly, the transition appears to be orderly, with Duke joining over a month before officially assuming the CEO role, allowing for a structured knowledge transfer from the outgoing CEO.
Each of these awards was听granted under听the听Company's Amended and Restated 2021 Inducement Plan (the "Inducement Plan") and otherwise will be subject to the terms and conditions of a restricted stock unit agreement under the Inducement Plan.
Mr. Duke received two restricted stock unit awards. The first restricted stock unit award covers 300,000 shares of the Company's common stock and is subject to vesting over three years, with one-third of the shares vesting on each of the first, second and third anniversary of the award's vesting commencement date of August 4, 2025, subject to Mr. Duke's continued service with the Company through each vesting date and potential acceleration upon certain terminations of employment.
The second restricted stock unit award covers 300,000 shares of the Company's common stock and will become eligible to vest based on the achievement of Company performance goals over a three year performance period between fiscal 2025 and fiscal 2027, subject to Mr. Duke's continued service with the Company through the last trading day of the calendar month in which achievement is certified and potential acceleration upon certain terminations of employment.
The stock unit awards were granted as inducements material to Mr. Duke's entering into employment with the听Company in accordance with听Nasdaq Listing Rule 5635(c)(4).
About听eHealth, Inc.
We're Matchmakers. For over 25 years, eHealth has helped millions of Americans find the healthcare coverage that fits their needs at a price they can afford. As a leading independent licensed insurance agency and advisor, eHealth offers across to over 180 health insurers, including national and regional companies.
For more information, visit or follow us on , , , and . Open positions can be found on our .听
Media Inquiries:
Lara Sasken
Chief Communications Officer
[email protected]
Investor Relations Contact:
Kate Sidorovich,听CFA
Senior Vice President, Investor Relations & Corporate Development
[email protected]听
View original content to download multimedia:
SOURCE eHealth, Inc.
FAQ
When will Derrick Duke become the new CEO of eHealth (EHTH)?
What compensation package did eHealth (EHTH) offer to new CEO Derrick Duke?
How will Derrick Duke's RSUs vest at eHealth (EHTH)?
When did Derrick Duke join eHealth (EHTH)?
